PLP1 alternative splicing in differentiating oligodendrocytes: Characterization of an exonic splicing enhancer

Journal of Cellular Biochemistry

Volumn 97, Issue 5, 2006, Pages 999-1016

  Wang, Erming ^a   Huang, Zhong ^b   Hobson, Grace M ^c,d   Dimova, Neviana ^a   Sperle, Karen ^c   McCullough, Andrew ^e   Cambi, Franca ^a,f  

^a UNIVERSITY OF KENTUCKY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Alternative splicing; ASF SF2; Exonic splicing enhancer; Oligodendrocytes; Proteolipid protein

Indexed keywords

ADENOSINE TRIPHOSPHATE; PHOSPHORUS 32; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 1; RNA; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; BIOINFORMATICS; ENHANCER REGION; EXON; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOCYTOCHEMISTRY; ISOTOPE LABELING; NERVE CELL CULTURE; NERVE CELL DIFFERENTIATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN BINDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALTERNATIVE SPLICING; AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELL LINEAGE; CELLS, CULTURED; ENHANCER ELEMENTS (GENETICS); EXONS; HUMANS; MUTATION; MYELIN PROTEOLIPID PROTEIN; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RNA SPLICE SITES; TRANSFECTION;

ANIMALIA;

EID: 33645239497     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20692     Document Type: Article

References (46)

1. Blencowe BJ. 2000. Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci 25:106-110.
2. Buratti E, Muro AF, Giombi M, Gherbassi D, Iaconcig A, Baralle FE. 2004. RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon. Mol Cell Biol 24: 1387-1400.
3. Caceres JF, Kornblihtt AR. 2002. Alternative splicing: Multiple control mechanisms and involvement in human disease. Trends Genet 18:186-193.
4. Caceres JF, Misteli T, Screaton GR, Spector DL, Krainer AR. 1997. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J Cell Biol 138:225-238.
5. Caceres JF, Screaton GR, Krainer AR. 1998. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev 12:55-66.
6. Cartegni L, Krainer AR. 2002. Disruption of an SF2/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet 30:377-384.
7. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. 2003. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 31:3568-3571.
8. Cazalla D, Zhu J, Manche L, Huber E, Krainer AR, Caceres JF. 2002. Nuclear export and retention signals in the RS domain of SR proteins. Mol Cell Biol 22:6871-6882.
9. Colwill K, Feng LL, Yeakley JM, Gish GD, Caceres JF, Pawson T, Fu XD. 1996. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. J Biol Chem 271:24569-24575.
10. Eisenbarth GS, Walsh FS, Nirenberg M. 1979. Monoclonal antibody to a plasma membrane antigen of neurons. Proc Natl Acad Sci USA 76:4913-4917.
11. Fu XD, Mayeda A, Maniatis T, Krainer AR. 1992. General splicing factors SF2 and SC35 have equivalent activities in vitro, and both affect alternative 5′ and 3′ splice site selection. Proc Natl Acad Sci USA 89:11224-11228.
12. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
13. Ge H, Manley JL. 1990. A protein factor, ASF, controls cell-specific alternative splicing of SV40 early pre-mRNA in vitro. Cell 62:25-34.
14. Gow A, Southwood CM, Lazzarini RA. 1998. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol 140:925-934.
15. Gudz TI, Schneider TE, Haas TA, Macklin WB. 2002. Myelin proteolipid protein forms a complex with integrins and may participate in integrin receptor signaling in oligodendrocytes. J Neurosci 22:7398-7407.
16. Gui JF, Tronchere H, Chandler SD, Fu XD. 1994. Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors. Proc Natl Acad Sci USA 91:10824-10828.
17. Hastings ML, Krainer AR. 2001. Pre-mRNA splicing in the new millennium. Curr Opin Cell Biol 13:302-309.
18. Hobson GM, Huang Z, Sperle K, Stabley DL, Marks HG, Cambi F. 2002. A PLP splicing abnormality is associated with an unusual presentation of PMD. Ann Neurol 52: 477-488.
19. Hobson G, Huang Z, Sperle K, Sistermans E, Rogan P, Garbern J, Kolodny E, Naidu S, Cambi F. 2005. Analysis of the contribution of splice site strength in the regulation of proteolipid protein and DM20 alternative splicing in differentiating oligodendrocytes in vitro. HUMU (in press).
20. Huang Z, Tang XM, Cambi F. 2002. Down-regulation of the retinoblastoma protein (rb) is associated with rat oligodendrocyte differentiation. Mol Cell Neurosci 19:250-262.
21. Jin Y, Suzuki H, Maegawa S, Endo H, Sugano S, Hashimoto K, Yasuda K, Inoue K. 2003. A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J 22: 905-912.
22. Jung M, Kramer E, Grzenkowski M, Tang K, Blakemore W, Aguzzi A, Khazaie K, Chlichlia K, von Blankenfeld G, Kettenmann H. 1995. Lines of murine oligodendroglial precursor cells immortalized by an activated neu tyrosine kinase show distinct degrees of interaction with axons in vitro and vivo. Eur J Neurosci 7:1245-1265.
23. Lamond AI, Spector DL. 2003. Nuclear speckles: A model for nuclear organelles. Nat Rev Mol Cell Biol 4:605-612.
24. LeVine SM, Wong D, Macklin WB. 1990. Developmental expression of proteolipid protein and DM20 mRNAs and proteins in the rat brain. Dev Neurosci 12:235-250.
25. Liu HX, Zhang M, Krainer AR. 1998. Identification of functional exonic splicing enhancer motifs recognized by individual SR proteins. Genes Dev 12:1998-2012.
26. McCullough AJ, Berget SM. 1997. G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol Cell Biol 17:4562-4571.
27. McCullough AJ, Berget SM. 2000. An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5′ splice sites. Mol Cell Biol 20:9225-9235.
28. Nave KA, Lai C, Bloom FE, Milner RJ. 1987. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci USA 84: 5665-5669.
29. Pollard AJ, Krainer AR, Robson SC, Europe-Finner GN. 2002. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3′-splice Site. J Biol Chem 277:15241-15251.
30. Rogan PK, Svojanovsky S, Leeder JS. 2003. Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. Pharmacogenetics 13:207-218.
31. Shy ME, Hobson G, Jain M, Boespflug-Tanguy O, Garbern J, Sperle K, Li W, Gow A, Rodriguez D, Bertini E, Mancias P, Krajewski K, Lewis R, Kamholz J. 2003. Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol 53:354-365.
32. Sommer I, Schachner M. 1981. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: An immunocytological study in the central nervous system. Dev Biol 83: 311-327.
33. Southwood CM, Garbern J, Jiang W, Gow A. 2002. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron 36:585-596.
34. Sporkel O, Uschkureit T, Bussow H, Stoffel W. 2002. Oligodendrocytes expressing exclusively the DM20 isoform of the proteolipid protein gene: Myelination and development. Glia 37:19-30.
35. Stamm S. 2002. Signals and their transduction pathways regulating alternative splicing: A new dimension of the human genome. Hum Mol Genet 11:2409-416.
36. Stamm S, Zhang MQ, Marr TG, Helfman DM. 1994. A sequence compilation and comparison of exons that are alternatively spliced in neurons. Nucleic Acids Res 22:1515-1526.
37. Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, Thanaraj TA, Soreq H. 2005. Function of alternative splicing. Gene 344:1-20.
38. Stecca B, Southwood CM, Gragerov A, Kelley KA, Friedrich VL, Jr., Gow A. 2000. The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. J Neurosci 20:4002-4010.
39. Tang XM, Strocchi P, Cambi F. 1998. Changes in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes. J Cell Biochem 68:128-137.
40. Thompson TE, Rogan PK, Risinger JI, Taylor JA. 2002. Splice variants but not mutations of DNA polymerase beta are common in bladder cancer. Cancer Res 62:3251-3256.
41. Timsit S, Sinoway MP, Levy L, Allinquant B, Stempak J, Staugaitis SM, Colman DR. 1992. The DM20 protein of myelin: Intracellular and surface expression patterns in transfectants. J Neurochem 58:1936-1942.
42. Wang J, Gao QS, Wang Y, Lafyatis R, Stamm S, Andreadis A. 2004. Tau exon 10, whose missplicing causes frontotemporal dementia, is regulated by an intricate interplay of cis elements and trans factors. J Neurochem 88:1078-1090.
43. Woppmann A, Will CL, Kornstadt U, Zuo P, Manley JL, Luhrmann R. 1993. Identification of an snRNP-associated kinase activity that phosphorylates arginine/serine rich domains typical of splicing factors. Nucleic Acids Res 21:2815-2822.
44. Xu X, Yang D, Ding JH, Wang W, Chu PH, Dalton ND, Wang HY, Bermingham JR, Jr., Ye Z, Liu F, Rosenfeld MG, Manley JL, Ross J, Jr., Chen J, Xiao RP, Cheng H, Fu XD. 2005. ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle. Cell 120:59-72.
45. Zahler AM, Neugebauer KM, Stolk JA, Roth MB. 1993. Human SR proteins and isolation of a cDNA encoding SRp75. Mol Cell Biol 13:4023-4028.
46. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415.